Mylan (MYL) Reduces EpiPen Cost After Clinton Comments
August 25, 2016 at 10:04 AM EDT
Shares of Mylan N.V. (MYL) were trading up +1.45 or +3.36 percent to $44.60 per share in Thursday's premarket after news that the company reduced the cost of its EpiPen injection for severe allergic reactions. The price reduction was in large part the result of presidential nominee Hillary Clinton calling recent price hikes to the ... READ MORE Read the rest of Mylan (MYL) Reduces EpiPen Cost After Clinton Comments at InvestorGuide.com .
